Australia is at risk of a fentanyl problem, but it is better prepared than North America. If the country can make the same kind of concerted effort it did to keep COVID-19 at bay, that could save thousands of lives.
The AMR Industry Alliance brings together over 100 biotechnology, diagnostic, generics and research-based biopharmaceutical companies and trade associations in the fight against AMR. RAND Europe has been commissioned by the AMR Industry Alliance to assess the progress of its members in contributing to tackling AMR.
Vaccine nationalism could prolong the pandemic and lead to preventable deaths. If some countries don't receive timely access to vaccines, then the virus will continue to spread in some populations, mutate further, and potentially render existing vaccines less effective.
Complex evaluations at multiple levels are gathering evidence for Guy’s and St Thomas’ Charity on societal determinants of health such as housing, debt, racism and labour markets. The findings will inform policy to help those most at risk of developing long-term conditions.
Without a vaccine, the worldwide economic impact of COVID-19 could be $3.4 trillion a year. But even when a vaccine is available, an unequal allocation of COVID-19 vaccines could cost the global economy up to $1.2 trillion a year in GDP.
RAND Europe's Sonja Marjanovic explains how changes in society have brought about opportunities for the pharmaceutical industry to innovate to better meet the needs of patients and health care systems.
Researchers found clear evidence concerning the negative health impacts of poor indoor temperature and ventilation. The study also identified that improved heating technologies and measures to increase the energy efficiency of buildings are effective in improving several key aspects of the indoor environment, though evidence on positive health impacts were mixed.
Researchers identified a number of key indicators that can be used to analyse elements of the oncology health system from different perspectives, and then used these indicators to create an overarching scorecard for oncology ecosystem performance.
The way people buy food is changing, and the sales of ethical and sustainable produce have increased. Eating food from outside the home is increasingly common, and what people consume still falls short of dietary guidelines. The reasons vary, and several policy levers may exist to influence people's food choices.
Innovating in response to public health challenges like COVID-19 does not always align well with pharmaceutical industry commercial models or shareholder expectations. More sustainable and scalable ways of incentivising innovation in response to infectious disease threats are needed.
As nations across the globe remain in lockdown to curb the spread of the COVID-19 pandemic, questions about the future of employment and workforce productivity emerge. During a recent webinar, RAND experts discussed how to get people back to work and improve productivity post COVID-19.
COVID-19 has shocked the world and caught most countries unprepared, forcing them to improvise. But amid all the confusion and fear, the power of individuals, organizations, and communities to think differently and to innovate shows what can be achieved when people are united by common, clear priorities and necessity.